Clear Cell Renal Cell Carcinoma With a Poorly-Differentiated Component: A Novel Variant Causing Potential Diagnostic Difficulty
Kanika Taneja(Henry Ford Health System), Sean R. Williamson(Cleveland Clinic), Craig Rogers(Norfolk and Norwich University Hospitals NHS Foundation Trust), Tatjana Antic(University of Chicago Medical Center), Maria Tretiakova(Charles University), Khaleel I. Al‐Obaidy(Indiana University School of Medicine), Nallasivam Palanisamy(Henry Ford Health System), Brooke E. Howitt(Cancer Institute (WIA)), Chia‐Sui Kao(Stanford Medicine), Justine A. Barletta(Brigham and Women's Hospital), Liang Cheng(Brown University), Nilesh Gupta(Henry Ford Health System), Matthew J. Wasco(Trinity Health), Shannon Carskadon(Henry Ford Health System), Ying‐Bei Chen(Memorial Sloan Kettering Cancer Center)
Unknown
January 1, 2019
Cited by 4
Related Papers
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
|Cancer Cell|2016|855
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma†
|Hepatology|2007|755
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705